Inhibition of the mammalian target of rapamycin (mTOR) as a potential antiepileptogenic therapy: from tuberous sclerosis to common acquired epilepsies - A review of the evidence
Year: 2026
Type: article
Abstract: mTOR inhibition shows antiepileptogenic effects in tuberous sclerosis mouse models and limited clinical data; evidence remains preclinical and not definitive.
Author: Iodice, Deborah
Language: English
Subfield: Genetics (clinical)
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7235393679
